Clay Siegall And His Contributions In Cancer Drug Development

Clay Siegall is the Co-founder and Chairman of Seattle Genetics. He established the company in 1998 and has been its Chief Executive Officer from November 2002 and its President since 2000. According to Clay, the need for advanced therapeutic drugs triggered the idea to start Seattle Genetics. He started the reputable firm while being driven by optimism that he would conquer cancer someday. Today, his company is ranked among the top companies conducting research on cancer therapy.

Seattle Genetics has a rich portfolio of clinical products targeting various types of cancer and autoimmune indications. What’s more? The company has become an admirable force to reckon with and is luring numerous companies to its ranks. For instance, Seattle Genetics collaborated with Takeda Pharmaceutical Company to develop the first FDA-accepted ADC invention, ADCETRIS. Dr. Siegell helped transform ADCETRIS into a global brand that has attained approval in at least 65 countries. The company is also keen to ensure it advances its ADC technology for the treatment of cancer.

Under Dr. Clay’s leadership, Seattle Genetics entered into several strategic agreements and drug development licenses not to mention the exclusive collaboration with Genentech. All the strategic collaborations that have been made under Dr. Siegall’s guidance have generated more than $350 million to date. Also, Dr. Clay Siegall steered Seattle Genetics’ capital raising endeavors and helped his company to collect more than a billion through public and private financing.

Clay’s resume reveals that he has more 25 years of experience in cancer research. His career began in 1988 when he worked for National Cancer Institute. In 1991, Siegall joined Bristol-Myers Squibb Pharmaceutical Research Institute until 1997. At present, Siegall serves on the Board of Directors in charge of numerous companies that include Ultragenyx Pharmaceutical and Alder BioPharmaceuticals. Also, Siegall is a renowned author and an innovative scientist who holds numerous patents.

Dr. Siegall has been a recipient of my awards throughout his career. For instance, his relentless abilities secured him the Pacific Northwest Ernst & Young Entrepreneur of the Year Award in 2012. The exceptional scientist earned his Ph.D. from George Washington University. He also holds a B.S from the University of Maryland.